| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. | Chief Legal Officer | Common Stock | 0 | $0 | $41.18 | 01 Aug 2024 | Direct |
| Cerevel Therapeutics Holdings, Inc. | Chief Legal Officer | Restricted Stock Units | 0 | $0 | $41.18 | 01 Aug 2024 | Direct |
| Cerevel Therapeutics Holdings, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 0 | 01 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings, Inc. | 01 Aug 2024 | 3 | $0 | 4 | Chief Legal Officer | 05 Aug 2024, 16:34 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 19 Jan 2024 | 1 | $0 | 4 | Chief Legal Officer | 23 Jan 2024, 17:31 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 19 Dec 2023 | 3 | -$292,945 | 4 | Chief Legal Officer | 21 Dec 2023, 20:21 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 05 Dec 2023 | 6 | -$445,725 | 4 | Chief Legal Officer | 07 Dec 2023, 19:45 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 06 Feb 2023 | 2 | $0 | 4 | Chief Legal Officer | 08 Feb 2023, 19:29 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 08 Aug 2022 | 3 | -$268,301 | 4 | Chief Legal Officer | 09 Aug 2022, 21:18 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 09 Feb 2022 | 1 | $0 | 4 | Chief Legal Officer | 11 Feb 2022, 17:43 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Chief Legal Officer | 03 Jun 2021, 16:34 |
| CERE | Cerevel Therapeutics Holdings, Inc. | 24 May 2021 | 0 | $0 | 3 | Chief Legal Officer | 28 May 2021, 16:47 |